KalVista Pharmaceuticals, Inc. (KALV)
14.91
-0.21
(-1.39%)
USD |
NASDAQ |
Feb 13, 16:00
14.90
-0.01
(-0.07%)
After-Hours: 20:00
KalVista Pharmaceuticals Profit Margin (Quarterly) : -361.4% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 8.09% |
| Iovance Biotherapeutics, Inc. | -135.3% |
| Plus Therapeutics, Inc. | -316.6% |
| BioStem Technologies, Inc. | 7.27% |
| Protokinetix, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -243.2% |
| Return on Assets | -84.60% |
| Return on Invested Capital | -97.51% |
| Gross Profit Margin (Quarterly) | 91.00% |
| Operating Margin (Quarterly) | -336.3% |
| Return on Net Operating Assets | -1.45K% |